Literature DB >> 21647148

Risk variant for schizophrenia in the neurogranin gene impacts on hippocampus activation during contextual fear conditioning.

S T Pohlack, F Nees, M Ruttorf, S H Witt, V Nieratschker, M Rietschel, H Flor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647148      PMCID: PMC3199731          DOI: 10.1038/mp.2011.66

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
Dysfunction of the hippocampus constitutes a core finding in schizophrenia. In the current study, we observed diminished hippocampal activations during the acquisition of contextual fear in healthy carriers of the genome-wide supported risk variant for schizophrenia, rs12807809 in neurogranin. Key features of schizophrenia, a highly heritable (60–80%), severe and common mental disorder, are declarative memory and contextual processing deficits.[1] Considerable research associated those impairments with structural and functional abnormalities in the hippocampus.[2] A recent genome-wide association study identified a relationship between schizophrenia and the single nucleotide polymorphism rs12807809 in the neurogranin gene.[3] Neurogranin is abundantly expressed in the hippocampus, a key region of contextual learning and discrimination, where it is involved in the formation of spatial memory and long-term potentiation in the CA1 region via the postsynaptic control of calmodulin availability during synaptic plasticity induction.[4] Earlier research trying to explore the effect of rs12807809 on brain functioning focused on tasks primarily mediated by the prefrontal cortex and did not detect any influence of neurogranin on cognition in schizophrenia.[5] Contextual fear conditioning is highly hippocampus dependent[6] and heritable (35–45%)[7] and constitutes a paradigm that is well suited to examine the impact of rs12807809 on cognitive and contextual processing. During contextual fear conditioning, an originally neutral context is presented several times together with an unconditioned threat stimulus and subsequently becomes a conditioned context, which elicits conditioned anxiety responses.[8] Impairments of contextual processing, for example, the interpretation of ambiguous stimuli based on the current spatial or temporal context or the inappropriate influence of distant contextual stimuli on performance, have been reported for schizophrenia (for a review, see Hemsley[1]) and represent a vulnerability factor for the development of the disorder.[9] Hence, we employed an imaging genetics approach in healthy volunteers to investigate the influence of rs12807809 on the hippocampus during a contextual fear conditioning paradigm using structural as well as functional magnetic resonance imaging (fMRI). The investigation of healthy participants permitted the investigation of a possible differential impact of the variant on hippocampal function unconfounded by variables typically present in patients (for example, medication or epistasis with other risk variants). To assess conditioning performance, we additionally quantified skin conductance responses as well as self-report measures. Furthermore, neuropsychological variables and hippocampal volumes were determined (see Supplementary Material for details). A total of 112 healthy volunteers of Caucasian descent (mean age (s.d.): 22.2 (4.1), 39 female), who previously underwent our conditioning paradigm were genotyped for rs12807809. Three of the study participants were CC homozygotes, 33 CT heterozygotes and 76 TT homozygotes (in Hardy–Weinberg equilibrium: P=1.00). Given the small number of CC individuals we pooled subjects carrying at least one C allele and compared them with TT homozygotes (N=76). Both groups were comparable with respect to demographic variables and memory performance (see Supplementary Information). Functional scans were acquired with an 1.5 Tesla scanner (Siemens, Erlangen, Germany) using an echoplanar imaging sequence and analyzed with SPM8. We used the General Linear Model to investigate genotype effects on the neural response to context conditioning. T1-weighted structural scans were conducted to manually assess hippocampal volumes with BRAINS2 (see Supplementary Information for details). The skin conductance responses and self-reports in both groups showed that subjects learned successfully to differentiate dangerous from safe contexts (see Supplementary Information). On the structural level, no differences in the hippocampal volumes were found. However, homozygous T-allele carriers showed significantly decreased activations in the left hippocampus during acquisition (see Figure 1), indicating impaired hippocampal activity during contextual learning.
Figure 1

Decreased hippocampal activation during acquisition of contextual fear in carriers of the rs12807809 risk allele (TT, N=76) compared with rs12807809 homozygotes (TC/CC, N=36). (a) Contrast (CS+>CS− x=−24, y=−37, z=−2, k=37; t=3.54, P<0.05) is family-wise error corrected (FWE) for the region of interest (ROI). Note that colors indicate t-scores. (b) Weighted-mean scores (CS+>CS−) in the ROI separate for left (red) and right (green) hippocampus during late acquisition.

Schizophrenia is a complex disorder and many factors contribute to the development of the fully-fledged phenotype, ranging from behavioral to neural characteristics. In our current sample of healthy subjects we could not find any differences on a behavioral level, however, the observed decreased hippocampal activation during contextual learning might represent a vulnerability factor for the development of schizophrenia. This corroborates previous findings from conditioning studies with 30–50% of schizophrenic patients showing no learning at all. Additionally, neuroimaging studies found decreased hippocampal activity during memory tasks in schizophrenics.[10] As independent replication of our results is necessary, conclusions must remain preliminary. However, investigating the impact of neurogranin on neural correlates of contextual processing in patients suffering from schizophrenia might further enhance our understanding of the disorder.
  9 in total

1.  A twin study of the genetics of fear conditioning.

Authors:  John M Hettema; Peter Annas; Michael C Neale; Kenneth S Kendler; Mats Fredrikson
Journal:  Arch Gen Psychiatry       Date:  2003-07

Review 2.  The development of a cognitive model of schizophrenia: placing it in context.

Authors:  David R Hemsley
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

Review 3.  Hippocampal pathology in schizophrenia.

Authors:  Stephan Heckers; Christine Konradi
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 4.  The hippocampal formation in schizophrenia.

Authors:  Carol A Tamminga; Ana D Stan; Anthony D Wagner
Journal:  Am J Psychiatry       Date:  2010-09-01       Impact factor: 18.112

5.  Neurogranin phosphorylation fine-tunes long-term potentiation.

Authors:  Ling Zhong; Kanwardeep S Kaleka; Nashaat Z Gerges
Journal:  Eur J Neurosci       Date:  2010-12-29       Impact factor: 3.386

6.  Dissociable roles for the hippocampus and the amygdala in human cued versus context fear conditioning.

Authors:  Andreas Marschner; Raffael Kalisch; Bram Vervliet; Debora Vansteenwegen; Christian Büchel
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

7.  Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms.

Authors:  Deanna M Barch; Cameron S Carter; Angus W MacDonald; Todd S Braver; Jonathan D Cohen
Journal:  J Abnorm Psychol       Date:  2003-02

8.  A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809.

Authors:  Gary Donohoe; James Walters; Derek W Morris; Andreia Da Costa; Emma Rose; April Hargreaves; Katie Maher; Eimear Hayes; Ina Giegling; Annette M Hartmann; Hans-Jürgen Möller; Pierandrea Muglia; Valentina Moskvina; Michael J Owen; Michael C O'Donovan; Michael Gill; Aiden Corvin; Dan Rujescu
Journal:  Schizophr Res       Date:  2010-11-26       Impact factor: 4.939

9.  Common variants conferring risk of schizophrenia.

Authors:  Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

  9 in total
  15 in total

1.  Converging evidence for an impact of a functional NOS gene variation on anxiety-related processes.

Authors:  Manuel Kuhn; Jan Haaker; Evelyn Glotzbach-Schoon; Dirk Schümann; Marta Andreatta; Marie-Luise Mechias; Karolina Raczka; Nina Gartmann; Christian Büchel; Andreas Mühlberger; Paul Pauli; Andreas Reif; Raffael Kalisch; Tina B Lonsdorf
Journal:  Soc Cogn Affect Neurosci       Date:  2016-01-08       Impact factor: 3.436

Review 2.  Genetic influences on the neural and physiological bases of acute threat: A research domain criteria (RDoC) perspective.

Authors:  Jennifer A Sumner; Abigail Powers; Tanja Jovanovic; Karestan C Koenen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-09-17       Impact factor: 3.568

3.  Neurogranin alters the structure and calcium binding properties of calmodulin.

Authors:  Laurel Hoffman; Anuja Chandrasekar; Xu Wang; John A Putkey; M Neal Waxham
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

4.  The DGCR5 long noncoding RNA may regulate expression of several schizophrenia-related genes.

Authors:  Qingtuan Meng; Kangli Wang; Tonya Brunetti; Yan Xia; Chuan Jiao; Rujia Dai; Dominic Fitzgerald; Amber Thomas; Lindsey Jay; Heather Eckart; Kay Grennan; Yuka Imamura-Kawasawa; Mingfeng Li; Nenad Sestan; Kevin P White; Chao Chen; Chunyu Liu
Journal:  Sci Transl Med       Date:  2018-12-13       Impact factor: 17.956

5.  Neurogranin regulates sensorimotor gating through cortico-striatal circuitry.

Authors:  John M Sullivan; Caleb A Grant; Ashlie N Reker; Lailun Nahar; Nicholas E Goeders; Hyung W Nam
Journal:  Neuropharmacology       Date:  2019-03-19       Impact factor: 5.250

6.  LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning.

Authors:  A Oliveros; K Wininger; J Sens; M K Larsson; X C Liu; S Choi; A Faka; L Schwieler; G Engberg; S Erhardt; D S Choi
Journal:  J Neuroimmunol       Date:  2017-09-28       Impact factor: 3.478

7.  Modulation ofTcf7l2 expression alters behavior in mice.

Authors:  Daniel Savic; Margaret G Distler; Greta Sokoloff; Nancy A Shanahan; Stephanie C Dulawa; Abraham A Palmer; Marcelo A Nobrega
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

8.  Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Yuka Yasuda; Kiyotaka Nemoto; Takashi Ohnishi; Motoyuki Fukumoto; Hidenaga Yamamori; Satomi Umeda-Yano; Takeya Okada; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

9.  Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome.

Authors:  Hongik Hwang; Matthew J Szucs; Lei J Ding; Andrew Allen; Xiaobai Ren; Henny Haensgen; Fan Gao; Hyewhon Rhim; Arturo Andrade; Jen Q Pan; Steven A Carr; Rushdy Ahmad; Weifeng Xu
Journal:  Biol Psychiatry       Date:  2020-07-29       Impact factor: 12.810

10.  Neurogranin targets calmodulin and lowers the threshold for the induction of long-term potentiation.

Authors:  Ling Zhong; Nashaat Z Gerges
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.